Gamlia Center experts reported the creation of two new multi-currency vaccines to prevent the corona virus, writes the Izvestia newspaper.
"We have developed two multivalent vaccines for the prevention of COVID-19 based on virus-like particles for nasal and parenteral use (administration by injection - editor). These drugs are against a number of genotypes," Tatyana Grebnikova, head of the molecular diagnostics laboratory of the Federal Research Center for Epidemiology, told Izvestia.